Easton Pharmaceuticals, Inc. (EAPH)

[mckinley1]

Interesting positive and developing information in article from Bloomberg concerning EAPH and agreement with NutraShop Global. EAPH expanding its reach with Strong Global Distribution, Strong Product Development, and Strong Partnerships. EAPH building, building, and building!

Easton Pharmaceuticals Announces North American Products Distribution and Intellectual Property Agreement With NutraShop Global
2015-03-19T12:00:00Z Email Print
Facebook
Twitter
Google+
LinkedIn
Save
Easton Pharmaceuticals Announces North American Products Distribution
and Intellectual Property Agreement With NutraShop Global Stores, a
Large Online Quality Wellness and Therapeutic Products Retailer;
Provides Other Updates
TORONTO, ON -- (Marketwired) -- 03/19/15 -- Easton Pharmaceuticals
Inc. (OTC PINK: EAPH), (the "Company") Announces it has executed a
distribution and intellectual property agreement for its full range
of OTC therapeutic and specialty products with NutraShop Global
Stores, Inc. currently serving thousands of trusting online customers
looking for Quality Life Wellness Products.
NutraShop Global Stores (http://www.nutrashopglobal.com) has been
successfully selling online to customers for several years across
North America who's customer base are searching for high quality
wellness products. NutraShop has established strong distribution
channels t
hat allow the company to sell house hold specialty brands
for less. Many of the products sold online can also be found in major
health and grocery stores across the United States and Canada, such
as Wholefoods and Canada's Loblaws Markets, a leading national
grocery chain. NutraShop is currently one of only 2 online retailers
to sell the MadeGood Foods brand as seen in every major grocery and
health retailer across Canada in stores such as wholefoods with the
soon anticipated entry in the much larger U.S. market.
NutraShop's mandate is a global trend; Health and Wellness with
Anti-Aging at the forefront without the side effects associated with
mainstream drugs. With the push to look better, feel better and live
longer healthier lives, NutraShop now features Easton's new line of
wellness products including a cosmetic grade Anti-Aging serum, Pain
Relief Gel and a Female Health product that each independently offer
pharmaceutical grade efficacy while clinically proven safe and
natural without the side effects that accompany many, if not all
drugs. Online sales launch of Eaton's 3 initial products are to be
introduced and launched at the upcoming trade shows including the
Total Health Show in mid April where attendance has been confirmed.
In addition to distributing Eastons OTC proprietary therapeutic
products, Easton Pharmaceuticals has also provided Nutrashop rights
and access to its transdermal delive
ry system and formulations that
are to be utilized in new products being jointly developed, one of
which includes a new children's topical product containing exotic
active ingredients to treat certain skin conditions.
NutraShop will compliment their existing road show by highlighting
Eastons products over the next two months at the highly anticipated
Yoga Show, Health Show and Mom Show throughout the greater Toronto
region and upcoming U.S trade shows reaching audiences up to 125,000
looking for natural safe ways to improve health and vitality as well
as new possible retail distribution channels.
Carla Pepe, CEO of Easton Pharmaceuticals, stated, "We have taken
another significant step forward with distribution of our ready to
launch OTC products to coincide with our operational retail Vaporizer
business. Our new distribution agreement firmly puts our products on
the map alongside several already established house hold brand names.
This partnership will set the wheels in motion for the long awaited
launch and sales of our OTC and therapeutic products as we showcase
our products to customers looking for effective natural solutions
online in the US and Canada and to thousands of people attending the
upcoming trade shows." Mrs. Pepe further commented, "Our partnership
with NutraShop will enable us to not only further our customer reach,
but to derive income and profit from the online sales and marketing
of non-competitive consumer goods. Moreover, this partnership will
help us gain valuable insight into online consumer sales behavior and
trends that can only help our business in the future. Shareholders
can also expect additional upcoming announcements including
anticipated store locations."
In other developments, Easton Pharmaceuticals is nearing the expected
completion of a 50 / 50 joint venture partnership agreement to be an
exclusive distributor in Mexico and all of Latin America and its over
400 Million population for a world patented diagnostic woman's
product that has in the past few months commenced sales in Walgreens
and other drug stores in both the United States and Canada. Once an
agreement has been finalized, the products, manufacturers and sales
projections will be disclosed which is forecasted to generate
significant, consistent and growing annual revenues protected by 12
year international patents.
About Easton Pharmaceuticals
Easton Pharmaceuticals is a specialty
ph
armaceutical company involved in various pharmaceutical sectors and
others industries such as medical marijuana. The Company previously
developed and owned an FDA approved wound healing drug and currently
owns topically-delivered drugs and other therapeutic products that
are all in various stages of development. Easton has completed an
acquisition that grants 40% ownership interest in Medicated Markets
International LLC assets; a California Licensed Medical Marijuana
Grower on 20 acres (3 acre growing area). Easton has also made
additional investments into AMFIL Technologies and their GroZone
anti-microbial airflow system needed for growing pesticide free
medicine, and currently have an exclusive option to purchase up to
49% in a medical marijuana grow-op business post granting of license
from Health Canada in Port Perry, Ontario, which has received a
letter to build from Health Canada. The company's gel formulation is
thought to be an innovative and unique transdermal delivery system
that can in the future be adaptable in the delivery of Cannabidiol
extracts.
For More Information Visit:
http://www.nutrashopglobal.com
http://www.eastonpharmaceuticalsinc.com
http://ecigmarkets.com/
http://finance.yahoo.com/q?s=eaph
https://twitter.com/eastonpharma
http://www.grozone.biz
Safe Harbor
This news release may contain forward-looking
statements or expressions within the meaning of the Private
Securities Litigation Reform Act of 1995 (The "Act"). In particular,
when certain words or phrases such as "hope," "positive,"
"anticipate," "pleased," "plan," "confident that," "believe,"
"expect," "possible" or "intent to" and similar conditional
expressions are expressed, they are intended to identify
forward-looking statements within the meaning of the Act and are
subject to the safe harbor created by the Act. Such statements are
subject to certain risks and uncertainties and actual results could
differ materially from those expressed in any of the forward-looking
statements. Any investment made into Easton Pharmaceuticals would be
classified as speculative and may contain risks. Such risks and
uncertainties include, but are not limited to, market conditions,
general acceptance of the company's products and technologies,
competitive factors, the ability to successfully complete additional
or adequate financing, government approvals or changes to proposed
laws and other risks and uncertainties further stated in the
company's financial reports and filings.
Contact:
Carla Pepe
Tel: [phone]
Tel: [phone]
Email: [e-mail]


Facebook Twitter Google+ LinkedIn